| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/06/1998 | CN1181010A A Pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 05/05/1998 | US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols |
| 05/05/1998 | US5747543 Anticarcinogenic agents and antihistamines |
| 05/05/1998 | US5747540 Enzyme inhibitors hydroxy indoleamides, coumarin amides and isothiocoumarin amides |
| 05/05/1998 | US5747532 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 05/05/1998 | US5747475 Chitosan-derived biomaterials |
| 05/05/1998 | US5747469 Methods and compositions comprising DNA damaging agents and p53 |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae |
| 05/05/1998 | US5747314 Nucleotides and genetic vectors |
| 05/05/1998 | US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae |
| 05/05/1998 | US5747288 Protein kinase required for Ras signal transduction |
| 05/05/1998 | US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae |
| 05/05/1998 | US5747275 Protein kinase required for RAS signal transduction |
| 05/05/1998 | US5747070 Methods for the treatment of herpes virus infections |
| 05/05/1998 | US5747061 Suspension of loteprednol etabonate for ear, eye, or nose treatment |
| 05/05/1998 | US5747034 Methods and materials for the induction of T cell anergy |
| 05/05/1998 | US5747026 Antioxidants |
| 05/05/1998 | US5747023 Cancer therapy using lymphotoxin |
| 05/05/1998 | CA2097589C Targeting of therapeutic agents using polysaccharides |
| 04/30/1998 | WO1998017826A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 04/30/1998 | WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | WO1998017798A1 Placental-derived prostate growth factors |
| 04/30/1998 | WO1998017797A1 ANTI-ErbB2 ANTIBODIES |
| 04/30/1998 | WO1998017794A1 Human eosinophil-derived basic protein |
| 04/30/1998 | WO1998017779A1 NOVEL FabH |
| 04/30/1998 | WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | WO1998017320A1 Use of hyaluronan in gene therapy |
| 04/30/1998 | WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 04/30/1998 | WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 04/30/1998 | WO1998017306A1 Method for increasing blood insulin levels in mammals |
| 04/30/1998 | WO1998017304A1 Anti-fibrotic agent assay |
| 04/30/1998 | WO1998017277A1 Amidine compounds for use in systemic treating ecto and/or endo parasitic diseases |
| 04/30/1998 | WO1998017268A2 Method of alleviating pain by means of combining tramadol with an nmda antagonist |
| 04/30/1998 | WO1998017264A1 Composition and method for topical treatment of active herpesviral infections |
| 04/30/1998 | WO1998017255A1 Preparation for the transport of an active substance across barriers |
| 04/30/1998 | WO1998017246A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 04/30/1998 | WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/30/1998 | DE19644422A1 Use of terpene(s) as immunosuppressant, anti-retroviral or anti-leukaemia |
| 04/30/1998 | CA2269711A1 Anti-fibrotic agent assay |
| 04/30/1998 | CA2269614A1 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 04/30/1998 | CA2268949A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 04/30/1998 | CA2268746A1 Placental-derived prostate growth factors |
| 04/30/1998 | CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | CA2268670A1 Preparation for transporting active ingredients through barriers |
| 04/30/1998 | CA2268476A1 Use of hyaluronan in gene therapy |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | CA2268016A1 Human eosinophil-derived basic protein |
| 04/29/1998 | EP0837872A1 A cytotoxicity-based genetic selection system (toxsel) |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837684A1 Pharmaceutical compositions containing a diclofenac salt and thiocolchicoside |
| 04/29/1998 | EP0837683A1 Preparation and use of sulfated oligosaccharides |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0537191B1 Treatment of organ transplantation rejection |
| 04/28/1998 | US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
| 04/28/1998 | US5744500 Administering to treat brain ischemia or stroke |
| 04/28/1998 | US5744499 Apoptosis-modulating factors influencing the intracellular concentration of methional/malondialdehyde |
| 04/28/1998 | US5744482 Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine |
| 04/28/1998 | US5744477 Administering an inhibitor in combination with restricting the caloric intake of the subject |
| 04/28/1998 | US5744476 Dopamine D1 agonists for the treatment of dementia |
| 04/28/1998 | US5744464 Dysmennhorea |
| 04/28/1998 | US5744460 Synergistic of mixture of protein kinase c-targeted antisense oligonucleotide and a chemotherapeutic agent, e.g.vinblastine; side effect reduction; anticarcinogenic- and tumor agents |
| 04/28/1998 | US5744457 Compositions and methods for inhibiting thrombogenesis |
| 04/28/1998 | US5744455 Reduction of anthracycline-induced cardiotoxicity |
| 04/28/1998 | US5744338 DNA encoding seryl tRNA synthetase from Staphylococcus aureus |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744167 Topically administering stannous halide or mixture of stannous halides |
| 04/28/1998 | US5744156 Use of a substance P antagonist for the treatment of skin reddening of neurogenic origin |
| 04/28/1998 | US5744151 Silver-based pharmaceutical compositions |
| 04/28/1998 | US5744123 Aerosol formulations containing P134a and particulate medicaments |
| 04/28/1998 | CA2077653C Phenyl butyl nitrone compositions for prevention of gastric ulceration |
| 04/28/1998 | CA2013050C Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof |
| 04/23/1998 | WO1998016834A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | WO1998016532A1 Triterpene derivatives with immunosuppressant activity |
| 04/23/1998 | WO1998016531A1 Triterpene derivatives with immunosupressant activity |
| 04/23/1998 | WO1998016242A1 Method of enhancing the delivery of growth factors |
| 04/23/1998 | WO1998016228A1 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS |
| 04/23/1998 | WO1998016227A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998009170A3 Methods and compositions for the detection of cervical cancer |
| 04/23/1998 | WO1998008546A3 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/23/1998 | WO1998004686A3 Pro-protein converting enzyme |
| 04/23/1998 | CA2269075A1 Method of enhancing the delivery of growth factors |
| 04/23/1998 | CA2268904A1 Diagnosis of spongiform encephalopathy |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0837138A2 Novel topoisomerase III |
| 04/22/1998 | EP0837137A2 Novel topoisomerase III |
| 04/22/1998 | EP0837136A2 Novel topoisomerase I |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0836853A1 Use of bradykinin antagonists for the manufacture of a medicament for treating Alzheimer's disease |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836851A1 Amidine compounds for use in treating ecto or endo parasitic diseases and systemic parasite control compositions |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836477A1 Antibacterial synergistic composition comprising rifabutin |
| 04/22/1998 | EP0836445A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/22/1998 | EP0836383A1 Combinations of inhibitors of farnesyl-protein transferase |
| 04/22/1998 | EP0836380A1 Fgf9 as a specific ligand for fgfr3 |
| 04/22/1998 | EP0764027A4 Method for protection against genotoxic mutagenesis |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |